(Q46735759)

24 December 2017

title

Differential regional and dose-related effects of asenapine on dopamine receptor subtypes (English)

1 reference

24 December 2017

0 references

Frank I Tarazi

1

1 reference

24 December 2017

Taylor Moran-Gates

2

1 reference

24 December 2017

Erik H F Wong

3

1 reference

24 December 2017

Brian Henry

4

1 reference

24 December 2017

Mohammed Shahid

5

1 reference

24 December 2017

publication date

24 February 2008

1 reference

24 December 2017

published in

Psychopharmacology

1 reference

24 December 2017

volume

198

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

103-111

1 reference

24 December 2017

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1098-7

Clozapine. A novel antipsychotic agent

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1098-7

Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers

21 January 2018

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs.

1 reference

12 December 2020

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

1 reference

12 December 2020

Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial

1 reference

12 December 2020

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

12 December 2020

Paranoid schizophrenia may be caused by dopamine hyperactivity of CA1 hippocampus

1 reference

12 December 2020

How antipsychotics work-from receptors to reality

1 reference

12 December 2020

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice

1 reference

12 December 2020

Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex

1 reference

12 December 2020

D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity

1 reference

12 December 2020

The functional anatomy of basal ganglia disorders

1 reference

12 December 2020

Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs

1 reference

12 December 2020

Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies

1 reference

12 December 2020

The neurobiology of cognition in schizophrenia.

1 reference

12 December 2020

Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions

1 reference

12 December 2020

Signaling mechanisms of the D3 dopamine receptor

1 reference

12 December 2020

New insights into the biology of schizophrenia through the mechanism of action of clozapine

1 reference

12 December 2020

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

1 reference

12 December 2020

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders

1 reference

12 December 2020

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

12 December 2020

Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia

1 reference

12 December 2020

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

1 reference

12 December 2020

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.

1 reference

12 December 2020

The phenomenology of experimentally induced amphetamine psychosis--preliminary observations

1 reference

12 December 2020

Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects

1 reference

12 December 2020

Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.

1 reference

12 December 2020

Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine.

1 reference

12 December 2020

Effects of newer antipsychotics on extrapyramidal function

1 reference

12 December 2020

Regional distribution of dopamine D4 receptors in rat forebrain

1 reference

12 December 2020

Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.

1 reference

12 December 2020

Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines

1 reference

12 December 2020

Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs

1 reference

12 December 2020

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

12 December 2020

Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.

1 reference

12 December 2020

Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming

1 reference

12 December 2020

Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.

1 reference

12 December 2020

1 reference

12 December 2020

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort

1 reference

12 December 2020

Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain

1 reference

12 December 2020

10.1007/S00213-008-1098-7

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017